However, severe infectious adverse events have been reported in previous randomized controlled trials (EXIST-3 study) among mTOR inhibitor users, resulting in severe pneumonia, septic shock, and subsequent participant deaths 19. This evidence concerns the gene MTOR and pneumonia.